Karlin Lionel

Lenalidomide Is Safe and Active in Waldenstrom Macroglobulinemia (WM)

P. Morel, X. Leleu, V. Leblond, 2014 .

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

J. Breeze, M. Dimopoulos, R. Vij, 2021, BMC cancer.

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

J. Shah, J. Breeze, M. Dimopoulos, 2020, BMC Cancer.